Concepedia

Therapeutic Switching

Therapeutic Switching is a clinical decision-making strategy within pharmacotherapy whereby a patient is transitioned from one disease-modifying therapy to another in the management of multiple sclerosis, distinguished by its intent to optimize efficacy, tolerability, or safety based on individual treatment response and disease activity.

259

Publications

10.8K

Citations

1.9K

Authors

784

Institutions

Publications per year

2017–2026

129

Parents

Publications

259

Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis

Katharine Harding, Owain Williams, Mark Willis et al. · JAMA Neurology · 2019 · 364 citations · Full text

, , +14

Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period

Juan J. Gómez‐Reino, Loreto Carmona · Arthritis Research & Therapy · 2006 · 291 citations · Full text

, , +16

Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis

Tim Spelman, Melinda Magyari, Fredrik Piehl et al. · JAMA Neurology · 2021 · 234 citations · Full text

, , +13

Rituximab versus fingolimod after natalizumab in multiple sclerosis patients

Peter Alping, Thomas Frisell, Lenka Novakova et al. · Annals of Neurology · 2016 · 229 citations

, , +16

Comparative Effectiveness of Rituximab and Other Initial Treatment Choices for Multiple Sclerosis

Mathias Granqvist, Malin Boremalm, Amyar Poorghobad et al. · JAMA Neurology · 2018 · 212 citations · Full text

, , +13

1–5 of 259

Authors

1.9K

  1. HB
    Helmut Butzkueven

    The University of Melbourne, Australia

    18 publications · 913 citations

    15

    h-index

  2. LK
    Ludwig Kappos

    University Hospital of Basel, Switzerland

    19 publications · 1.4K citations

    14

    h-index

  3. JL
    Jeannette Lechner‐Scott

    John Hunter Hospital, Australia

    12 publications · 701 citations

    12

    h-index

  4. MT
    María Trojano

    University of Bari Aldo Moro, Italy

    13 publications · 834 citations

    12

    h-index

  5. TK
    Tomáš Kalinčík

    The University of Melbourne, Australia

    12 publications · 665 citations

    11

    h-index

1–5 of 1.9K

Institutions

784

  1. Biogen (United States)

    Cambridge, United States

    15 h-index

    54 publications

    2.3K citations

  2. Monash University

    Melbourne, Australia

    14 h-index

    48 publications

    1.5K citations

  3. The Royal Melbourne Hospital

    Melbourne, Australia

    14 h-index

    53 publications

    4.7K citations

  4. The University of Melbourne

    Melbourne, Australia

    13 h-index

    32 publications

    1.9K citations

  5. Karolinska Institutet

    Stockholm, Sweden

    13 h-index

    45 publications

    4.4K citations

  6. University Hospital of Basel

    Basel, Switzerland

    13 h-index

    44 publications

    3.3K citations

  7. University of Bari Aldo Moro

    Bari, Italy

    13 h-index

    20 publications

    1.2K citations

  8. Novartis (Switzerland)

    Basel, Switzerland

    12 h-index

    40 publications

    1.7K citations

1–8 of 784

Venues

  1. Multiple Sclerosis Journal

    MSJ · 29 publications · 1.1K citations

    20

    h-index

  2. Multiple Sclerosis and Related Disorders

    24 publications · 746 citations

    16

    h-index

  3. European Journal of Neurology

    11 publications · 495 citations

    11

    h-index

  4. Neurology

    12 publications · 1K citations

    11

    h-index

  5. Therapeutic Advances in Neurological Disorders

    11 publications · 385 citations

    11

    h-index

1–5